The Clorox Company
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2022 | 2023 | 2024 | 2025 | 2026 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 7.11B | 7.39B | 7.09B | 7.10B | 6.72B | -5.4% | |
| Cost of Revenue | (4.56B) | (4.48B) | (4.04B) | (3.89B) | (3.88B) | -0.4% | |
Gross Profit | 2.54B | 2.91B | 3.05B | 3.21B | 2.84B | -11.5% | |
| Operating Expenses | |||||||
| Research & Development | (132.00M) | (138.00M) | (126.00M) | (121.00M) | (116.00M) | -4.1% | |
| Selling, General & Administrative | (1.66B) | (1.92B) | (2.17B) | (1.89B) | (1.07B) | -43.7% | |
| General & Administrative | (954.00M) | (1.18B) | (1.34B) | (1.12B) | (317.00M) | -71.8% | |
| Selling & Marketing | (709.00M) | (734.00M) | (832.00M) | (770.00M) | (749.00M) | -2.7% | |
| Depreciation & Amortization | (224.00M) | (236.00M) | (235.00M) | (219.00M) | — | -100.0% | |
Operating Income (EBIT) | 719.00M | 823.00M | 723.00M | 1.18B | 1.66B | 41.2% | |
| Non-Operating Items | |||||||
| Interest Income | 5.00M | 16.00M | 23.00M | 9.00M | 8.00M | -11.1% | |
| Interest Expense | (106.00M) | (90.00M) | (90.00M) | (88.00M) | (130.00M) | 47.7% | |
| Other Income/Expenses (Net) | -112.00M | -585.00M | -325.00M | -99.00M | -871.00M | 779.8% | |
Income Before Tax | 607.00M | 238.00M | 398.00M | 1.08B | 791.00M | -26.6% | |
| Income Tax Expense | (136.00M) | (77.00M) | (106.00M) | (254.00M) | (190.00M) | -25.2% | |
Net Income | 462.00M | 149.00M | 280.00M | 810.00M | 587.00M | -27.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $4 | $1 | $2 | $7 | $5 | -26.5% | |
| Weighted Avg Shares Outstanding | 123.11M | 123.59M | 124.17M | 123.53M | 121.78M | -1.4% | |
| Weighted Avg Shares Outstanding (Diluted) | 123.91M | 124.18M | 124.80M | 124.29M | 122.13M | -1.7% | |
EBITDA | 937.00M | 564.00M | 723.00M | 1.39B | 921.00M | -33.5% |
Explore CLX
CLX in the Consumer Defensive
Large Cap